Fiocruz
Most Brazilian states report severe acute respiratory syndrome (SRAG) at alert, risk, or high-risk levels, according to Fiocruz's InfoGripe bulletin released on April 29. Cases are driven mainly by influenza A and respiratory syncytial virus (RSV), which circulate more in autumn and winter. Exceptions are Rio de Janeiro, São Paulo, and Rio Grande do Sul.
Iniulat ng AI
Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.